Ninlaro

Multiple Myeloma

Treatment

2 FDA approvals

6 Active Studies for Ninlaro

Treatment for

Multiple Myeloma

What is Ninlaro

IxazomibThe Generic name of this drug

Treatment SummaryIxazomib is an oral medication used to treat multiple myeloma. It is taken in combination with lenalidomide and dexamethasone, and is usually prescribed to patients who have received at least one prior therapy. It works by inhibiting proteasomes (proteins that help break down proteins) and is sold under the brand name Ninlaro. It was found to be as effective as bortezomib (the first proteasome inhibitor approved for multiple myeloma) in controlling myeloma growth and preventing bone loss. The drug was approved by the FDA in 2015.

Ninlarois the brand name

image of different drug pills on a surface

Ninlaro Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Ninlaro

Ixazomib

2015

Approved as Treatment by the FDA

Ixazomib, commonly known as Ninlaro, is approved by the FDA for 2 uses which include Multiple Myeloma and Multiple Myeloma (MM) .

Multiple Myeloma

Used to treat Multiple Myeloma (MM) in combination with Dexamethasone

Multiple Myeloma (MM)

Used to treat Multiple Myeloma (MM) in combination with Dexamethasone

Effectiveness

How Ninlaro Affects PatientsTests done in laboratories have shown that ixazomib can kill multiple myeloma cells. In tests on mice, ixazomib was able to slow down tumor growth.

How Ninlaro works in the bodyIxazomib is a type of medication that stops the 20S proteasome from breaking down proteins. This causes proteins to build up and stop the cell from functioning properly, leading to cell death.

When to interrupt dosage

The amount of Ninlaro is contingent upon the diagnosed affliction. The dosage fluctuates in accordance with the technique of delivery noted in the table below.

Condition

Dosage

Administration

Multiple Myeloma

, 2.3 mg, 3.0 mg, 4.0 mg

, Oral, Capsule, Capsule - Oral

Warnings

There are 20 known major drug interactions with Ninlaro.

Common Ninlaro Drug Interactions

Drug Name

Risk Level

Description

Albutrepenonacog alfa

Minor

Ixazomib may decrease the excretion rate of Albutrepenonacog alfa which could result in a higher serum level.

Almasilate

Minor

Ixazomib may decrease the excretion rate of Almasilate which could result in a higher serum level.

Antithrombin III human

Minor

Ixazomib may decrease the excretion rate of Antithrombin III human which could result in a higher serum level.

Baricitinib

Minor

Ixazomib may decrease the excretion rate of Baricitinib which could result in a higher serum level.

Benserazide

Minor

Ixazomib may decrease the excretion rate of Benserazide which could result in a higher serum level.

Ninlaro Toxicity & Overdose RiskLess than 1% of patients taking Ixazomib have reported liver-related illnesses such as liver damage, fatty liver, hepatitis, or bile duct blockage. Taking Ixazomib while pregnant can cause harm to the baby, so it is important for women of reproductive age to avoid becoming pregnant while taking this drug.

image of a doctor in a lab doing drug, clinical research

Ninlaro Novel Uses: Which Conditions Have a Clinical Trial Featuring Ninlaro?

11 studies are presently assessing the utility of Ninlaro in the treatment of Multiple Myeloma.

Condition

Clinical Trials

Trial Phases

Multiple Myeloma

6 Actively Recruiting

Phase 1, Phase 2

Ninlaro Reviews: What are patients saying about Ninlaro?

5Patient Review

10/25/2018

Ninlaro for Multiple Myeloma

I just finished my seventh cycle of this treatment, and it was much more tolerable than Pomalyst, Kyprolis, or Velcade. That being said, all of those treatments worked for me in one way or another.

1Patient Review

10/16/2016

Ninlaro for Multiple Myeloma

I will update this review in three weeks after taking the medication for an extended period of time.

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ninlaro

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How long does it take NINLARO to work?

"The median time it took for patients to see their first response was shorter when taking the NINLARO regimen compared to the placebo regimen. However, it should be noted that it took longer for some patients to see a response."

Answered by AI

Is NINLARO the same as Velcade?

"The drugs Ninlaro and Velcade are both targeted therapies for multiple myeloma that work in the same way by inhibiting proteasomes."

Answered by AI

Is NINLARO a chemotherapy drug?

"The anticancer drug Ninlaro is used to treat multiple myeloma. It is used in combination with the drugs lenalidomide and dexamethasone."

Answered by AI

What are the side effects of NINLARO?

"The following text describes some of the possible side effects of a medication. Diarrhea, nausea, vomiting, constipation, dry eyes, blurred vision, or eye redness/itching/discharge may occur. These side effects can be severe in some cases. To prevent or relieve these side effects, your doctor may prescribe medication."

Answered by AI